BackNorthwest Biotherapeutics Overview

Northwest Biotherapeutics Other Liabilities

Track Northwest Biotherapeutics's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Northwest Biotherapeutics Other Liabilities History

Loading

Northwest Biotherapeutics vs. peers: Other Liabilities Comparison

Loading

Northwest Biotherapeutics Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Northwest Biotherapeutics (NWBO) FAQ

As of the most recent data (June 2026), NWBO shows a other liabilities of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NWBO's other liabilities is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Northwest Biotherapeutics is outperforming or lagging.

Tracking NWBO's other liabilities over time shows whether Northwest Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Northwest Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.

Northwest Biotherapeutics's other liabilities is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.